Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has a partnership agreement with Merck & Co. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is headquartered in Marina del Rey, California.
Earnings for Armata Pharmaceuticals, Inc. (ARMP)
Earnings in 2023 (TTM): $-69,045,000
According to Armata Pharmaceuticals, Inc.'s latest financial reports the company's current earnings (TTM) are $-69,045,000. The earnings displayed on this page is the company's Pretax Income.
Earnings history of Armata Pharmaceuticals, Inc.
Annual Earnings
| Year | Income Before Tax | Net Income |
|---|---|---|
| 2023 | $-69,045,000 | $-69,045,000 |
| 2022 | $-36,917,000 | $-36,888,000 |
| 2021 | $-23,155,000 | $-23,219,000 |
| 2020 | $-22,181,000 | $-22,815,000 |
| 2019 | $-19,479,000 | $-19,025,000 |
| 2018 | $-12,438,000 | $-12,110,000 |
| 2017 | $-14,140,000 | $-12,838,000 |
| 2016 | $-19,394,000 | $-18,838,000 |
| 2015 | $-589,000 | $-516,000 |
| 2014 | $23.11 M | $23.11 M |
| 2013 | $-58,411,000 | $-58,411,000 |
| 2012 | $-4,260,000 | $-1,110,000 |
| 2008 | $-20,720,000 | $-20,720,000 |
| 2007 | $-16,127,000 | $-16,127,000 |
| 2006 | $-33,990,000 | $-33,990,000 |
| 2005 | $-19,198,000 | $-19,198,000 |
| 2004 | $-14,257,000 | $-14,257,000 |
| 2003 | $-14,833,000 | $-14,833,000 |
| 2002 | $-23,767,000 | $-23,767,000 |
| 2001 | $-27,170,000 | $-27,170,000 |
| 2000 | $-47,655,691 | $-47,655,691 |
| 1999 | $-26,700,000 | $-26,700,000 |
| 1998 | $-8,700,000 | $-8,700,000 |
| 1997 | $-14,200,000 | $-14,200,000 |
| 1996 | $-26,000,000 | $-26,000,000 |
| 1995 | $-9,900,000 | $-9,900,000 |
| 1994 | $-8,400,000 | $-8,400,000 |
| 1993 | $-5,100,000 | $-5,100,000 |